During the past decade, Cardiology Research Associates of New Brunswick conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cardiology Research Associates of New Brunswick" are "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "Cardiology Research Associates of New Brunswick" in a lesser frequency.

Most popular intervention types in "Cardiology Research Associates of New Brunswick" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Research Associates of New Brunswick" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Research Associates of New Brunswick". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Cardiology Research Associates of New Brunswick, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Research Associates of New Brunswick, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".